Literature DB >> 17142869

The search for alternative sources of human pluripotent stem cells.

Adam Schulman1.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 17142869     DOI: 10.1385/SCR:1:4:291

Source DB:  PubMed          Journal:  Stem Cell Rev        ISSN: 1550-8943            Impact factor:   5.739


× No keyword cloud information.
  3 in total

1.  Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres.

Authors:  Young Chung; Irina Klimanskaya; Sandy Becker; Joel Marh; Shi-Jiang Lu; Julie Johnson; Lorraine Meisner; Robert Lanza
Journal:  Nature       Date:  2005-10-16       Impact factor: 49.962

2.  Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells.

Authors:  Chad A Cowan; Jocelyn Atienza; Douglas A Melton; Kevin Eggan
Journal:  Science       Date:  2005-08-26       Impact factor: 47.728

3.  Generation of nuclear transfer-derived pluripotent ES cells from cloned Cdx2-deficient blastocysts.

Authors:  Alexander Meissner; Rudolf Jaenisch
Journal:  Nature       Date:  2005-10-16       Impact factor: 49.962

  3 in total
  3 in total

Review 1.  Stem cells in amniotic fluid as new tools to study human genetic diseases.

Authors:  Nicol Siegel; Margit Rosner; Michaela Hanneder; Alessandro Valli; Markus Hengstschläger
Journal:  Stem Cell Rev       Date:  2007-12       Impact factor: 5.739

2.  MePR: a novel human mesenchymal progenitor model with characteristics of pluripotency.

Authors:  Marco Miceli; Gianluigi Franci; Carmela Dell'Aversana; Francesca Ricciardiello; Francesca Petraglia; Annamaria Carissimo; Lucia Perone; Giuseppe Maria Maruotti; Marco Savarese; Pasquale Martinelli; Massimo Cancemi; Lucia Altucci
Journal:  Stem Cells Dev       Date:  2013-05-24       Impact factor: 3.272

3.  Human amniotic fluid stem cells as a model for functional studies of genes involved in human genetic diseases or oncogenesis.

Authors:  Margit Rosner; Helmut Dolznig; Katharina Schipany; Mario Mikula; Oliver Brandau; Markus Hengstschläger
Journal:  Oncotarget       Date:  2011-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.